The HABITS trial, a randomized controlled study, assessed the safety of hormone replacement therapy (HRT) in breast cancer survivors with menopausal symptoms but was terminated early due to concerns about increased cancer recurrence. Among 442 women followed for a median of four years, the HRT group had a significantly higher
